Enfusion Appoints Oleg Movchan Interim Chief Executive Officer

Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the "Board") has

Enfusion, Inc. (“Enfusion”) (NYSE:ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the “Board”) has appointed Oleg Movchan, currently a member of the Board, as Interim Chief Executive Officer, effective August 21, 2022. Mr. Movchan succeeds Thomas Kim, who has resigned as CEO and as a Director of the Company so that he can spend more time with his family.

Total
0
Shares
Related Posts